Clinical trial
PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)
NCT00221702 · University Hospital, Bordeaux, Other · Completed
Key facts
| NCT number | NCT00221702 |
|---|---|
| Title | PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial) |
| Official title | Randomized, Multicenter Phase III Trial Comparing Adjuvant Treatment With PegIntron Over 36 Months Versus Reference Treatment With IntronA Over 18 Months in Cutaneous Melanoma Patients AJCC Stage II (>=1.5 mm Clinically Node Negative) |
| Acronym | EADO |
| Lead sponsor | University Hospital, Bordeaux, Other |
| Collaborators | Schering-Plough Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Melanoma, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | PegIntron, intron A |
| Enrollment | 898 |
| Start date | Jun 1, 2003 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Sep 22, 2005 |
| Last update posted | Oct 13, 2010 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: